packageAlemtuzumab

alemtuzumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alemtuzumab is a monoclonal antibody used to treat multiple sclerosis and certain leukemias, including chronic lymphocytic leukemia and T-cell prolymphocytic leukemia. It remains authorised in the European Union, though one EU product has been withdrawn, and it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q420164 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:alemtuzumab
ATC codes:L01XC04, L04AA34, L04AG06
DrugBank:DB00087
Wikidata:Q420164
molar mass:145454 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown